NCT00184093View on ClinicalTrials.gov

Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2009

Conditions
Uterine Cervical Cancer
Interventions
DRUG

Gemcitabine

Gemcitabine weekly x 6 wks with concurrent external radiation

Trial Locations (1)

90033

USC/Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT00184093 - Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma | Biotech Hunter | Biotech Hunter